These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8103894)

  • 1. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
    Houben JJ; Nicolai G
    Lancet; 1993 Sep; 342(8874):806-7. PubMed ID: 8103894
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
    Loeliger EA
    Lancet; 1993 Sep; 342(8874):806; author reply 807. PubMed ID: 8103893
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
    [No Abstract]   [Full Text] [Related]  

  • 5. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Visser J
    Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
    Fremes SE; Levinton C; Naylor CD; Chen E; Christakis GT; Goldman BS
    Eur J Cardiothorac Surg; 1993; 7(4):169-80. PubMed ID: 8481254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
    Sagnol P; Delahaye JP
    Presse Med; 1991 Feb; 20(7):287-90. PubMed ID: 1826353
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
    Verstraete M; Brown BG; Chesebro JH; Ekeström S; Harker LA; Henderson AH; Jewitt DE; Oliver MF; Sleight P
    Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
    Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
    Pfisterer M; Jockers G; Meier B; Schmitt HE; Stulz P; Hasse J; Grädel E; Burkart F
    Helv Chir Acta; 1987 Feb; 53(4):497-500. PubMed ID: 3494713
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH
    Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.
    Chong BH
    Aust N Z J Med; 1992 Dec; 22(6):645-6. PubMed ID: 1489286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
    Loeliger EA
    Schweiz Med Wochenschr; 1988 Mar; 118(12):447-9. PubMed ID: 3259724
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long?
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Thromb Res Suppl; 1990; 12():11-21. PubMed ID: 2082483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Urquhart J; Thijssen H; Struijker Boudier HA
    Ned Tijdschr Geneeskd; 1994 Jan; 138(1):46-7. PubMed ID: 8289961
    [No Abstract]   [Full Text] [Related]  

  • 17. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    van der Meer FJ; Rosendaal FR
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2223-4; author reply 2224-5. PubMed ID: 8247172
    [No Abstract]   [Full Text] [Related]  

  • 18. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
    Houben JJ; Nicolai G
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2225; author reply 2225-6. PubMed ID: 8247173
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts.
    Agnew TM; French JK; Neutze JM; Whitlock RM; Brandt PW; Kerr AR; Webber BJ; Rutherford JD
    Aust N Z J Med; 1992 Dec; 22(6):665-70. PubMed ID: 1489290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Théroux P
    Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.